type of glp 1 drugs New GLP-1 Guidelines for 2 Diabetes in 2025 GLP-1 Drugs: Fighting Diabetes and

These medications are not licensed by the MHRA for alcohol use disorder and should not replace specialist addiction services

Wong WY, et al

Hemoglobin and Iron handling in brain after subarachnoid hemorrhage and the effect of Deferoxamine on early brain injury

Views on how the impact of these treatments for obesity and diabetes could exceed those projected in our central scenario and the potential for further reductions in mortality and morbidity as the therapeutic landscape for incretin-based drugs expands beyond obesity and diabetes Considerations for how to incorporate these insights into future improvement bases Underwriting and claims considerations Key findings 1